ArticleMolecular cancer therapeutics2026

Targeting the ERα DBD-LBD Interface with Mitoxantrone Disrupts Receptor Function through Proteasomal Degradation.

Han Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.